Stephen J. Harland
London, ENG NW12BU, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 20, 2020
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 23, 2017
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.
Journal: BJU international
Published: November 29, 2014
Myocardial uptake of 99mTc-HDP and reduced perfusion on CT in subacute myocardial infarction.
Journal: Clinical nuclear medicine
Published: November 13, 2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 16, 2013
Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).
Journal: British journal of cancer
Published: June 24, 2013
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.
Journal: The Lancet. Oncology
Published: September 22, 2012
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 05, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026